標(biāo)題: Titlebook: Handbook for Venous Thromboembolism; Gregory Piazza,Benjamin Hohlfelder,Samuel Z. Goldh Book 2015 Springer International Publishing Switze [打印本頁] 作者: Tyler 時(shí)間: 2025-3-21 16:54
書目名稱Handbook for Venous Thromboembolism影響因子(影響力)
書目名稱Handbook for Venous Thromboembolism影響因子(影響力)學(xué)科排名
書目名稱Handbook for Venous Thromboembolism網(wǎng)絡(luò)公開度
書目名稱Handbook for Venous Thromboembolism網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Handbook for Venous Thromboembolism被引頻次
書目名稱Handbook for Venous Thromboembolism被引頻次學(xué)科排名
書目名稱Handbook for Venous Thromboembolism年度引用
書目名稱Handbook for Venous Thromboembolism年度引用學(xué)科排名
書目名稱Handbook for Venous Thromboembolism讀者反饋
書目名稱Handbook for Venous Thromboembolism讀者反饋學(xué)科排名
作者: 違法事實(shí) 時(shí)間: 2025-3-21 23:14 作者: 說笑 時(shí)間: 2025-3-22 01:57
,Pathophysiology of Deep Vein Thrombosis and Pulmonary Embolism: Beyond Virchow’s Triad,flammation, and hypercoagulability. The extent of the PE, the patient’s underlying cardiopulmonary reserve, and compensatory neurohumoral adaptations determine the overall hemodynamic impact. The right ventricle (RV) plays a central role in PE pathophysiology. A sudden increase in RV afterload due t作者: 暴發(fā)戶 時(shí)間: 2025-3-22 05:38
Diagnosis of Deep Vein Thrombosis: Incorporating Clinical Suspicion with Laboratory Testing and Imatrategy that combines an assessment of clinical probability of the diagnosis with use of D-dimer testing and imaging when appropriate maximizes diagnostic accuracy. Venous ultrasound is the imaging test of choice for most patients with suspected DVT.作者: 記憶 時(shí)間: 2025-3-22 08:42 作者: Contend 時(shí)間: 2025-3-22 14:54 作者: nutrition 時(shí)間: 2025-3-22 21:00
Advanced Therapy for Venous Thromboembolism: Understanding the Role of Systemic Fibrinolysis, Catheary embolism (PE) syndromes. Advanced therapies for acute PE include systemic fibrinolysis, catheter-based “pharmacomechanical” intervention, and surgical pulmonary embolectomy. Choosing a particular advanced therapy depends on the individual patient’s risk for adverse outcomes due to VTE and for ma作者: 我說不重要 時(shí)間: 2025-3-22 22:20 作者: NOVA 時(shí)間: 2025-3-23 03:27
Anticoagulation for Venous Thromboembolism: Selecting the Optimal Parenteral and Oral Anticoagulantunfractionated heparin, low-molecular-weight heparin, fondaparinux, argatroban, bivalirudin, warfarin, and the non-vitamin K oral anticoagulants (NOACs) rivaroxaban, dabigatran, apixaban, and edoxaban. The NOACs represent a major advance in anticoagulation for VTE with superior safety and equivalent作者: amnesia 時(shí)間: 2025-3-23 08:52
Long-Term Management of Venous Thromboembolism: Strategies for Reducing the Risk of Recurrence,optimal duration and drug regimen requires an individualized assessment of the patient’s long-term risk of recurrence as well as bleeding. Warfarin and non-vitamin K oral anticoagulants (NOACs) have been validated for extended duration anticoagulation to prevent recurrent unprovoked VTE. Aspirin als作者: 不吉祥的女人 時(shí)間: 2025-3-23 12:09
Chronic Thromboembolic Pulmonary Hypertension: A Pathophysiologic Basis for Diagnosis and Managemen persistent macrovascular obstruction, pulmonary vasoconstriction, and a secondary small-vessel arteriopathy. CTEPH used to be considered a rare complication but is now recognized to occur in 2–4 % of patients after PE. While patients may be initially asymptomatic, CTEPH frequently progresses to deb作者: NOMAD 時(shí)間: 2025-3-23 17:05
Post-thrombotic Syndrome: Recognizing and Treating a Debilitating Complication of Deep Vein Thrombotremity edema, hyperpigmentation, and, in advanced cases, venous ulceration. PTS results in substantial disability, loss of functional status, and health care expenditure. Compression therapy, including graduated compression stockings, comprises the cornerstone of PTS therapy.作者: 樣式 時(shí)間: 2025-3-23 19:19 作者: GEN 時(shí)間: 2025-3-24 01:42
https://doi.org/10.1007/978-3-030-86897-0 myocardial infarction and stroke. VTE is a common complication of hospitalization and is the most preventable cause of death among hospitalized patients. While the majority of patients who develop VTE do so as outpatients, many have been hospitalized for medical or surgical illness within 3 months 作者: Virtues 時(shí)間: 2025-3-24 05:13
https://doi.org/10.1057/978-1-137-53165-0 injury, stasis, and hypercoagulability. The majority of VTE patients presents with a combination of multiple risk factors that result in venous thrombosis. Common acquired risk factors include advanced age, malignancy, immobility, inflammation, and recent trauma, surgery, and hospitalization. Throm作者: FLIT 時(shí)間: 2025-3-24 10:15 作者: 閑逛 時(shí)間: 2025-3-24 14:43
The Shifting Global Economic Architecturetrategy that combines an assessment of clinical probability of the diagnosis with use of D-dimer testing and imaging when appropriate maximizes diagnostic accuracy. Venous ultrasound is the imaging test of choice for most patients with suspected DVT.作者: refine 時(shí)間: 2025-3-24 16:22
https://doi.org/10.1007/978-981-97-7578-1 a timely diagnosis of pulmonary embolism (PE). Diagnosis of acute PE is often challenging because the disease presents as a variety of clinical syndromes, ranging from pleuritic pain to cardiac arrest. A diagnostic algorithm that integrates an assessment of clinical probability with appropriate lab作者: harpsichord 時(shí)間: 2025-3-24 19:25 作者: guzzle 時(shí)間: 2025-3-25 01:30 作者: 熒光 時(shí)間: 2025-3-25 06:13 作者: ACME 時(shí)間: 2025-3-25 10:22
https://doi.org/10.1007/978-1-4939-2371-7unfractionated heparin, low-molecular-weight heparin, fondaparinux, argatroban, bivalirudin, warfarin, and the non-vitamin K oral anticoagulants (NOACs) rivaroxaban, dabigatran, apixaban, and edoxaban. The NOACs represent a major advance in anticoagulation for VTE with superior safety and equivalent作者: 喊叫 時(shí)間: 2025-3-25 14:11
https://doi.org/10.1007/978-3-030-27596-9optimal duration and drug regimen requires an individualized assessment of the patient’s long-term risk of recurrence as well as bleeding. Warfarin and non-vitamin K oral anticoagulants (NOACs) have been validated for extended duration anticoagulation to prevent recurrent unprovoked VTE. Aspirin als作者: fulcrum 時(shí)間: 2025-3-25 17:33
https://doi.org/10.1007/978-1-137-06809-5 persistent macrovascular obstruction, pulmonary vasoconstriction, and a secondary small-vessel arteriopathy. CTEPH used to be considered a rare complication but is now recognized to occur in 2–4 % of patients after PE. While patients may be initially asymptomatic, CTEPH frequently progresses to deb作者: 無表情 時(shí)間: 2025-3-25 21:13
https://doi.org/10.1007/978-981-15-2031-0tremity edema, hyperpigmentation, and, in advanced cases, venous ulceration. PTS results in substantial disability, loss of functional status, and health care expenditure. Compression therapy, including graduated compression stockings, comprises the cornerstone of PTS therapy.作者: VOC 時(shí)間: 2025-3-26 02:10
The Short Narratives of E. M. Forstertion of thromboprophylaxis continues to be inconsistent in the U.S., Canada, and worldwide. Quality Improvement initiatives, including decision support-based strategies, have the potential to improve prophylaxis utilization and reduce the incidence of VTE during hospitalization. The approach to VTE 作者: 大罵 時(shí)間: 2025-3-26 07:14 作者: Project 時(shí)間: 2025-3-26 12:26 作者: 衣服 時(shí)間: 2025-3-26 13:33 作者: ACME 時(shí)間: 2025-3-26 16:52
The Sheer Joy of Celestial Mechanicsdetermine the overall hemodynamic impact. The right ventricle (RV) plays a central role in PE pathophysiology. A sudden increase in RV afterload due to PE can lead to RV dilation and hypokinesis, RV ischemia, and ultimately acute RV failure.作者: Arable 時(shí)間: 2025-3-26 21:36
https://doi.org/10.1007/978-981-97-7578-1omes, ranging from pleuritic pain to cardiac arrest. A diagnostic algorithm that integrates an assessment of clinical probability with appropriate laboratory testing and imaging modalities is critical. Contrast-enhanced chest computed tomogram (CT) is the predominant imaging test used to diagnosis PE.作者: RUPT 時(shí)間: 2025-3-27 02:56 作者: Heterodoxy 時(shí)間: 2025-3-27 09:17 作者: 拱墻 時(shí)間: 2025-3-27 10:05 作者: ACRID 時(shí)間: 2025-3-27 14:42 作者: 意見一致 時(shí)間: 2025-3-27 19:11
The Short Narratives of E. M. Forsterprevention among hospitalized and postoperative patients must consider the patient population and individual risk while integrating the use of mechanical and pharmacological modalities when indicated.作者: 輕觸 時(shí)間: 2025-3-27 23:57
Inferior Vena Cava Filters: Recognizing Indications for Placement and Retrieval, PE would likely be fatal. Retrievable IVC filters are inserted to provide temporary protection from PE during such periods of increased vulnerability or when interruption of anticoagulation is necessary. IVC filters should be retrieved as soon as they are no longer necessary.作者: SPASM 時(shí)間: 2025-3-28 05:47
Prevention of Venous Thromboembolism: An Evidence-Based Approach to Thromboprophylaxis,prevention among hospitalized and postoperative patients must consider the patient population and individual risk while integrating the use of mechanical and pharmacological modalities when indicated.作者: hardheaded 時(shí)間: 2025-3-28 09:51
Book 2015ology. Efficient algorithms for diagnosis and exclusion of DVT and PE are emphasized. An state-of-the-art review of current techniques for the management of high risk VTE, including submassive and massive PE, is presented. The novel oral anticoagulants are revolutionizing the way VTE is treated and are covered in detail.?作者: 巨碩 時(shí)間: 2025-3-28 11:55 作者: calumniate 時(shí)間: 2025-3-28 17:08 作者: Peristalsis 時(shí)間: 2025-3-28 20:45 作者: 知道 時(shí)間: 2025-3-28 23:05
,Pathophysiology of Deep Vein Thrombosis and Pulmonary Embolism: Beyond Virchow’s Triad,determine the overall hemodynamic impact. The right ventricle (RV) plays a central role in PE pathophysiology. A sudden increase in RV afterload due to PE can lead to RV dilation and hypokinesis, RV ischemia, and ultimately acute RV failure.作者: 不能妥協(xié) 時(shí)間: 2025-3-29 06:54 作者: Flinch 時(shí)間: 2025-3-29 09:26 作者: 自然環(huán)境 時(shí)間: 2025-3-29 13:01 作者: Tincture 時(shí)間: 2025-3-29 18:49
Long-Term Management of Venous Thromboembolism: Strategies for Reducing the Risk of Recurrence,d non-vitamin K oral anticoagulants (NOACs) have been validated for extended duration anticoagulation to prevent recurrent unprovoked VTE. Aspirin also plays a role in the prevention of recurrence in patients with unprovoked VTE.作者: excursion 時(shí)間: 2025-3-29 21:21
https://doi.org/10.1007/978-1-137-06809-5ost effective therapy for CTEPH. Pulmonary vasodilators offer patients with CTEPH who are inoperable and those with post-operative persistent or recurrent pulmonary hypertension the potential for improved symptoms and functional capacity.作者: Catheter 時(shí)間: 2025-3-30 00:54 作者: intoxicate 時(shí)間: 2025-3-30 05:47 作者: senile-dementia 時(shí)間: 2025-3-30 09:29
